New Treatment Target for Fibromyalgia: Inflammation in the Brain
Neuroinflammation in the brain as a therapeutic target
Fibromyalgia
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain - PMC
LDN has an anti-inflammatory effect on fibromyalgia ; fibromyalgia has an inflammatory component.
Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies
Supplementing with palmitoylethanolamide (PEA) further reduced pain when added to pregabalin and duloxetine.